Karolinska Institutet Study Links Substance Use to Suicide Risk

Individuals diagnosed with a substance use disorder face an increased risk of suicidal behavior, according to a population-based register study published on September 22, 2026, in the journal Molecular Psychiatry. Researchers at Karolinska Institutet analyzed Swedish national registries to evaluate how familial history and severe drug or alcohol dependence intersect with mental health outcomes, nyheter.ki.se reported.

• Patients with substance use disorders exhibit a higher risk of suicidal behavior than those without such diagnoses.
• A family history of substance use problems acts as a marker for heightened vulnerability to suicidal acts.
• Specialist healthcare providers must screen for suicide risk routinely among individuals presenting with co-occurring psychiatric and dependence diagnoses.

Family History of Substance Use Increases Suicide Risk

The study, titled "Lifetime substance use disorder and suicidal behaviour: a population-based familial co-aggregation register study," examines how severe dependence correlates with self-harm and suicide attempts. "Våra resultat tyder på att familjehistorik med substansbrukssyndrom inte bara är en riskfaktor för egna beroendeproblem utan också kan vara en markör för ökad risk för suicidalt beteende," Khemiri stated in Swedish, which translates to the finding that family history serves as a dual marker for both personal dependence and elevated suicide risk.

Because the research relies strictly on diagnoses recorded within specialist medical care, the findings predominantly reflect the more severe end of the spectrum for substance use disorders.

Clinical Implications for Specialist Psychiatric Care

Healthcare professionals treating patients with alcohol and drug dependence must account for these elevated odds during routine assessments. Khemiri emphasized that clinical staff meeting patients with addiction require specific training in recognizing and evaluating suicide risk, much like protocols established for other severe psychiatric conditions.

“Studien visar också behovet av mer forskning om insatser som kan förebygga suicid hos personer med beroendesjukdomar,” Khemiri stated, pointing to the urgent demand for targeted preventative measures tailored to addiction medicine. The data indicate that co-occurring psychiatric diagnoses compound the danger, necessitating multidisciplinary care models that integrate substance treatment with acute mental health monitoring.

Study Uses Swedish Population Data

The investigation utilized Swedish population-based register data, linking familial relationships with lifetime medical diagnoses. Alongside Khemiri, the research team included Ralf Kuja-Halkola, Henrik Larsson, Isabell Brikell, Zheng Chang, Brian M. D’Onofrio, Antti Latvala, and Paul Lichtenstein. Funding details and potential conflicts of interest are available directly within the published paper in Molecular Psychiatry.

Investigators caution that because the dataset is drawn entirely from Swedish administrative and health registers, the extent to which these risk ratios transfer to healthcare systems in other countries remains uncertain.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.